Ohio § 5164.755 Supplemental drug rebate program

Ohio Statutes

§ 5164.755 — Supplemental drug rebate program

Ohio § 5164.755

Title 51Public Welfare

Ch. 5164Medicaid State Plan Services

This text of Ohio § 5164.755 (Supplemental drug rebate program) is published on Counsel Stack Legal Research, covering Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ohio Rev. Code Ann. § 5164.755 (2026).

Text

The medicaid director, in rules adopted under  section5164.02of the Revised Code, may establish and implement a  supplemental drug rebate program under which drug manufacturers  may be required to provide the department of medicaid a  supplemental rebate as a condition of having the drug  manufacturers' drug products covered by the medicaid program  without prior approval. The department may receive a supplemental  rebate negotiated under the program for a drug dispensed to a  medicaid recipient pursuant to a prescription or a drug purchased  by a medicaid provider for administration to a medicaid recipient  in the provider's primary place of business.

If the director establishes a supplemental drug rebate  program, the director shall consult with drug manufacturers  regarding the establi

Free access — add to your briefcase to read the full text and ask questions with AI

The medicaid director, in rules adopted under section5164.02of the Revised Code, may establish and implement a supplemental drug rebate program under which drug manufacturers may be required to provide the department of medicaid a supplemental rebate as a condition of having the drug manufacturers' drug products covered by the medicaid program without prior approval. The department may receive a supplemental rebate negotiated under the program for a drug dispensed to a medicaid recipient pursuant to a prescription or a drug purchased by a medicaid provider for administration to a medicaid recipient in the provider's primary place of business.

If the director establishes a supplemental drug rebate program, the director shall consult with drug manufacturers regarding the establishment and implementation of the program.